July 31, 2026
“Q32 Bio Inc. (NASDAQ:QTTB) shares surged 60% on Monday after the biotechnology company announced positive topline results from the 36-week Part B analysis of its SIGNAL-AA Phase 2a study evaluating bempikibart for the treatment of severe and very severe alopecia… Continue Reading…
July 28, 2026
“AstraZeneca’s medicine Wainua did not meet its goal of reducing deaths and recurrent heart-related emergencies in people with a rare heart condition. Shares slumped and were on track for the worst day in over six years. Jefferies analysts said the… Continue Reading…
July 22, 2026
“Fourth-quarter revenue skyrocketed 133% year-over-year to $641.6 million, propelled by strong defense demand. Adjusted quarterly earnings reached $1.84 per share, comfortably beating the consensus analyst estimate of $1.47 per share. The company’s funded backlog climbed to $1.2 billion, up from… Continue Reading…
July 21, 2026
“… Quarterly revenue rose 133% vs. prior year to $641.6 million, while annual revenue was up 141% to 1.977 billion. Analysts had expected sales of $556 million for the quarter and $1.892 billion for the fiscal year, according to FactSet. Earnings… Continue Reading…
July 16, 2026
“In recent days, Alibaba Group has sued the U.S. Department of Defense to challenge its designation as a Chinese military-linked company, while also facing accusations from Anthropic that operators tied to its Qwen AI lab illicitly accessed Claude AI models… Continue Reading…
July 15, 2026
“…Shares of Aditxt, Inc. (ADTX) surged 40% overnight heading into Tuesday as investors assessed a new filing showing a newly disclosed 10% holder after the company’s $150 million Ignite Proteomics spin-off plan. ADTX stock surged 92% on Monday after rocketing… Continue Reading…
July 14, 2026
“Gap issued mixed fiscal first-quarter results, missing on the top line but beating on the bottom. CEO Richard Dickson told CNBC sales at Old Navy were worse than expected after the brand’s spring and summer assortment failed to land with… Continue Reading…
July 10, 2026
“Mercury raised $200 million at a $5.2 billion valuation, a 49% jump over its last round, led by TCV and including Sequoia, Andreessen Horowitz and Coatue, CNBC has learned exclusively. The fundraising comes weeks after Mercury received conditional approval from… Continue Reading…
July 9, 2026
“…The share price recently closed at US$93.26, with returns of 43.4% year to date and 36.0% over the last year… On this basis, the DCF model suggests an intrinsic value of about $67.97 per share for Microchip Technology, compared with… Continue Reading…
Recent Comments